Currently, DSC has been extensively studied in the diagnosis, differential diagnosis and prognosis evaluation of brain lymphoma, but it has not obtained a uniform standard. By combining DSC imaging features, this study investigated the imaging features and diagnostic value of several types of tumors such as primary brain lymphoma. At the same time, this study obtained data from brain lymphoma patients by data collection and set up different groups to conduct experimental studies to explore the correlation between IVIM-MRI perfusion parameters and DSC perfusion parameters in brain lymphoma. Through experimental research, it can be seen that the combination of two perfusion imaging techniques can more fully reflect the blood flow properties of the lesion, which is beneficial to determine the nature of the lesion.
Purpose Bickerstaff's brainstem encephalitis(BBE) is considered a scarce variant of Miller-Fisher syndrome(MFS) and Guillain–Barré syndrome (GBS) but accounts for a significant proportion of brainstem encephalitis.Detailed knowledge of their neuroimaging manifestations is of paramount importance for a correct early diagnosis and proper management of the affected patients.In this study,We sought to characterize neuroimaging findings,including the morphology and manifestation of advanced MR imaging and differential diagnosis.Methods Seven BBE patients (5 males,2 females; mean age 42.5 ± 5.7 years,range 17 to 63 years) were retrospectively studied using conventional MRI (T1- and T2- weighted,FLAIR sequences,postcontrast T1-weighted images) and advanced MRI such as diffusion-weighted imaging (DWI) and proton magnetic resonance spectroscopy (MRS).The apparent diffusion coefficient (ADC) values and the MRS ratio were calculated in lesion regions.Results1. The distribution of these lesions typically include bilateral and symmetrical involvement of the mesencephalon,thalamus,tegmentum,infratentorial periaqueductal region,and the periventricular region surrounding the third and fourth ventricles involving white and gray matter; additional supratentorial white matter is not involved.2. MRI axial T2-weighted images and FLAIR sequences showed nearly symmetrical hyperintense signal changes with slightly spotty,patchy,or confluent homogeneous enhancement on postcontrast T1-weighted images without necrosis or hemorrhage.3. DWI signal was enhanced,and the apparent diffusion coefficient (ADC) map signal was slightly increased.ADC values of BBE lesions were in the range of 1.21 to 1.67 × 10−3 mm/s2 (mean 1.38 ± 0.66 × 10−3 mm/s2).4. Proton MR spectrum showed a slight increase in choline and a relative decrease in NAA peak,while Lipid and Lac doublet were not detected.Conclusion Advanced MRI imaging can provide important physiological and metabolic information of BBE and complement the morphological findings of the clinical conventional MRI.
Currently, DSC has been extensively studied in the diagnosis, differential diagnosis, and prognosis evaluation of brain lymphoma, but it has not obtained a uniform standard. By combining DSC imaging features, this study investigated the imaging features and diagnostic value of several types of tumors such as primary brain lymphoma. At the same time, this study obtained data from brain lymphoma patients by data collection and set up different groups to conduct experimental studies to explore the correlation between IVIMMRI perfusion parameters and DSC perfusion parameters in brain lymphoma. Through experimental research, it can be seen that the combination of two perfusion imaging techniques can more fully reflect the blood flow properties of the lesion, which is beneficial to determine the nature of the lesion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.